Visual hallucinations associated with Parkinson disease

Archives of Neurology

Volumn 53, Issue 12, 1996, Pages 1265-1268

  Sanchez Ramos, Juan R ^a,b,d   Ortoll, Rick ^a   Paulson, George W ^c  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c OHIO STATE UNIVERSITY   (United States)

^d UNIVERSITY OF SOUTH FLORIDA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLINERGIC RECEPTOR BLOCKING AGENT; COCAINE; LEVODOPA;

ADULT; AGE; AGED; ARTICLE; DEPRESSION; DISEASE ASSOCIATION; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PARKINSON DISEASE; PRIORITY JOURNAL; QUESTIONNAIRE; SLEEP DISORDER; VISUAL HALLUCINATION;

EID: 0030461622     PISSN: 00039942     EISSN: None     Source Type: Journal    
DOI: 10.1001/archneur.1996.00550120077019     Document Type: Article

References (25)

1. Lhermitte J. Les Hallucinations. Paris, France: G Doin & Co; 1951.
2. Fischer R. Visions, hallucinations, consciousness, hemispheres, symbols. J Altered States Consciousness. 1970;1:145-151.
3. Tanner CM, Vogel C, Goetz CG, Klawans HI. Hallucinations in Parkinson's disease: a population study. Ann Neurol. 1983;14:136-144.
4. Rondor P, DeRecondo J, Coigner A, Zeigler M. Mental disorders in Parkinson's disease after treatment with L-dopa. Adv Neurol. 1984;40:259-269.
5. Nausieda P, Weiner WJ, Kaplan I, et al. Sleep disruption in the course of chronic levodopa therapy: an early feature of the levodopa psychosis. Clin Neuropharmacol. 1982;5:183-194.
6. Kluver H. Neurobiology of normal and abnormal perception. In: Hoch P, Zubin J, eds. Psychopathology of Perceptions. New York, NY: Grune & Stratton; 1965.
7. Brown JW. Hallucinations imagery and the microstructure of perception. In: Frederiks JAM, ed. Handbook of Clinical Neurology. New York, NY: Elsevier Science Inc; 1985;1(45):351-372.
8. Alroe CJ, Mclntkyre JN. Visual hallucinations: the Charles Bonnet syndrome and bereavement. Med J Aust. 1983;2:674-675.
9. Celesia GC, Barr AN. Psychosis and other psychiatric manifestations of levodopa therapy. Arch Neurol. 1970;23:193-200.
10. Moskovitz C, Moses H III, Klawans HL. Levodopa-induced psychosis, a kindling phenomenon. Am J Psychiatry. 1978;135:669-675.
11. Comella CL, Tanner CM, Ristanovic RK. Polysomnographic sleep measures in Parkinson's disease patients with treatment-induced hallucinations. Ann Neurol. 1993;34:710-714.
12. Glantz R, Bieliauskas L, Paleologos N. Behavioral indicators of hallucinosis in levodopa-treated Parkinson's disease. Adv Neurol. 1986;45:417-420.
13. Sacks OW, Kol MS, Messeloff CR, Schwartz WF. Effects of levodopa in parkinsonian patients with dementia. Neurology. 1972;22:516-519.
14. Sandyck R, Gillman MA. Depression as a cause of hallucinations in Parkinson's disease. Clin Neuropharmacol. 1985;8:199-200.
15. Patterson MB, Schnell AH, Martin RJ, Mendez MF, Smyth KA, Whitehouse PJ. Assessment of behavioral and affective symptoms in Alzheimer's disease. J Geriatr Psychiatry Neurol. 1990;3:21-30.
16. Berrios GE, Brook P. Visual hallucinations and sensory delusions in the elderly. Br J Psychiatry. 1984;144:662-664.
17. Olbrich HM, Lodemann E, Engelmeier MP. Optical hallucinations in the aged with diseases of the eye. Z Gerontol. 1987;20:227-229.
18. Pederzoli M, Girotti F, Scigliano G, et al. L-Dopa long-term treatment in Parkinson's disease: age related side effects. Neurology. 1983;33:259-269.
19. Goetz CG, Tanner CM, Klawans HL. Pharmacology of hallucinations induced by long-term drug therapy. Am J Psychiatry. 1982;139:494-497.
20. Mitchell J, Vierkant AD. Delusions and hallucinations of cocaine abusers and paranoid schizophrenics: a comparative study. J Psychol. 1991;125:301-310.
21. McKee AC, Levine DN, Kowall NW, Richardson EP Jr. Peduncular hallucinosis associated with isolated infarction of the s. nigra pars reticulata. Ann Neurol. 1990;27:500-504.
22. Dawson DJ, Enoch BA, Shepherd DI. Formed visual hallucinations with pituitary adenomas. BMJ. 1984;289:414.
23. Bolgert F, Josse MO, Blustain J, Brunet P, Laplane D. Delirium occurring in the course of Guillain-Barré syndrome with dysautonomia. Neurology. 1992; 42(suppl 3):294.
24. Friedman JH. The management of the levodopa psychoses. Clin Neuropharmacol. 1991;14:283-295.
25. Goetz CG, Stebbins GT. Mortality and hallucinations in nursing home patients with advanced Parkinson's disease. Neurology. 1995;45:669-671.